So, repotrectinib is this inhibitor thing, and it’s meant to target specific kinase proteins, which are linked to lung cancer types like ROS1-positive NSCLC and NTRK-fusion cancers. It comes in capsule form, and the key stuff in it is called repotrectinib. Each capsule is 40 mg.
The first 14 days, you take one a day, then after that, you take two a day. You get these capsules in bottles with 60 in each one. It works by stopping these kinases, like TRK, ROS1, and ALK, which really fuel cancer growth in the types of cancer it’s meant for.
